Pharmafile Logo

TVF Communications

- PMLiVE

First patient treated with Sangamo’s gene-editing tech

SB-913 uses ZFN technology to insert a corrective gene into the liver cells DNA location

Roche Basel Switzerland

Roche gets first approval for haemophilia A therapy

The first-in-class therapy wins US marketing licence three months earlier than expected

- PMLiVE

Ketchum London’s CEO Denise Kaufmann heads for the US

The UK agency's deputpy CEO Jo-ann Robertson will move into Kaufmann's former role

ThromboGenics bolsters leadership team

Appoints Susan Schneider as CMO and Vinciane Vangeersdaele as CCO

- PMLiVE

Lucid picks up rare disease and orphan drugs trophy at PMEA 2017

Judges praised the AbbVie project for its impressive reach

- PMLiVE

Uptake Strategies and Sanofi win capability development prize at PMEA

Judges praised their programme’s pragmatic design and huge scalability

- PMLiVE

EMA approves GSK’s triple COPD therapy

Trelegy can now be marketed as a maintenance treatment in Europe

- PMLiVE

Sanofi’s diabetes IMPACT programme wins at PMEA 2017

Takes home first place in Excellence in Demonstrating Economic and Societal Value

National Institute for Health and Care Excellence NICE logo

NICE backs two advanced breast cancer drugs after price cuts

An estimated 8,000 women will be eligible to receive the drugs due to discounts

- PMLiVE

AbbVie named PMEA 2017 Company of the Year

Sees off strong competition from Amgen and Sanofi

- PMLiVE

The EarthWorks wins PMEA Support Agency of the Year

Edges out Complete Medical Communications and Makara Health to take the title

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links